Benralizumab in Patients With Inadequate Response to Anti-IL5 Monoclonal Antibody Therapies
Clinical trial NCT03470311 · COMPLETED
Trial details
- NCT number
- NCT03470311
- Sponsor
- McMaster University
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-26
- Primary completion
- 2022-06-14
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.